Novel glial-neuronal signalling by coactivation of metabotropic glutamate and beta-adrenergic receptors in rat hippocampus.

Por Winder, D G, Ritch, P S, Gereau, R W, Conn, P J
Publicado em 1996

A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.

Por Conn, P J, Sanders-Bush, E, Hoffman, B J, Hartig, P R
Publicado em 1986

Metabotropic glutamate receptors: From the workbench to the bedside

Por Nicoletti, F., Bockaert, J., Collingridge, G.L., Conn, P.J., Ferraguti, F., Schoepp, D.D., Wroblewski, J.T., Pin, J.P.
Publicado em 2010

Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M(1) muscarinic receptors

Por Maltese, M., Martella, G., Madeo, G., Fagiolo, I., Tassone, A., Ponterio, G., Sciamanna, G., Burbaud, P., Conn, P.J., Bonsi, P., Pisani, A.
Publicado em 2014

A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling

Por Noetzel, M. J., Gregory, K. J., Vinson, P. N., Manka, J. T., Stauffer, S. R., Lindsley, C. W., Niswender, C. M., Xiang, Z., Conn, P. J.
Publicado em 2013

SELECTIVE POTENTIATION OF THE METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 2 BLOCKS PHENCYCLIDINE-INDUCED HYPERLOCOMOTION AND BRAIN ACTIVATION

Por HACKLER, E. A., BYUN, N. E., JONES, C. K., WILLIAMS, J. M., BAHEZA, R., SENGUPTA, S., GRIER, M. D., AVISON, M., CONN, P. J., GORE, J. C.
Publicado em 2010

Role for the M(1) Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice

Por Gould, R. W., Dencker, D., Grannan, M., Bubser, M., Zhan, X., Wess, J., Xiang, Z., Locuson, C., Lindsley, C. W., Conn, P. J., Jones, C. K.
Publicado no ACS Chem Neurosci (2015)

Synthesis and biological characterization of a series of novel diaryl amide M(1) antagonists

Por Poslusney, Michael S., Sevel, Christian, Utley, Thomas J., Bridges, Thomas M., Morrison, Ryan D., Kett, Nathan R., Sheffler, Douglas J., Niswender, Colleen M., Daniels, J. S., Conn, P. J., Lindsley, Craig W., Wood, Michael R.
Publicado em 2012

Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij rats

Por D’Amore, V., Santolini, I., Celli, R., Lionetto, L., De Fusco, A., Simmaco, M., van Rijn, C.M., Vieira, E., Stauffer, S.R., Conn, P.J., Bosco, P., Nicoletti, F., van Luijtelaar, G., Ngomba, R.T.
Publicado no Neuropharmacology (2014)

Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats

Por D’Amore, V., Santolini, I., van Rijn, C.M., Biagioni, F., Molinaro, G., Prete, A., Conn, P.J., Lindsley, C.W., Zhou, Y., Vinson, P.N., Rodriguez, A.L., Jones, C.K., Stauffer, S.R., Nicoletti, F., van Luijtelaar, G., Ngomba, R.T.
Publicado em 2012

Potentiation of M(1) Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model

Por Ghoshal, A, Rook, J M, Dickerson, J W, Roop, G N, Morrison, R D, Jalan-Sakrikar, N, Lamsal, A, Noetzel, M J, Poslusney, M S, Wood, M R, Melancon, B J, Stauffer, S R, Xiang, Z, Daniels, J S, Niswender, C M, Jones, C K, Lindsley, C W, Conn, P J
Publicado no Neuropsychopharmacology (2016)

N-Aryl Piperazine Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators Possess Efficacy in Preclinical Models of NMDA Hypofunction and Cognitive Enhancement

Por Gregory, K.J., Herman, E.J., Ramsey, A.J., Hammond, A.S., Byun, N.E., Stauffer, S.R., Manka, J.T., Jadhav, S., Bridges, T.M., Weaver, C.D., Niswender, C.M., Steckler, T., Drinkenburg, W.H., Ahnaou, A., Lavreysen, H., Macdonald, G.J., Bartolomé, J.M., Mackie, C., Hrupka, B.J., Caron, M.G., Daigle, T.L., Lindsley, C.W., Conn, P.J., Jones, C.K.
Publicado em 2013